by Avi Kapoor | May 7, 2026 | General
BioCryst Pharmaceuticals Inc (NASDAQ:BCRX) reported upbeat earnings for the first quarter on Wednesday. The company posted quarterly earnings of 14 cents per share which beat the analyst consensus estimate of 5 cents per share. The company reported quarterly sales of...
by Vandana Singh | May 7, 2026 | General
Entrada Therapeutics, Inc. (NASDAQ:TRDA) stock is trading lower on Thursday as the stock reacts to news regarding its clinical trial data in Duchenne muscular dystrophy patients. Phase 1/2 Data Falls Short Of Investor Expectations The company on Thursday released...
by Akanksha Bakshi | May 7, 2026 | General
GeneDx Holdings Corp. (NASDAQ:WGS) shares are rebounding as investors step back in after the genetic testing company’s sharp post-earnings sell-off earlier this week. What Happened The stock had plunged nearly 49% on May 5 after the company cut its full-year revenue...
by Vandana Singh | May 7, 2026 | General
Zoetis Inc. (NYSE:ZTS) shares are trading lower on Thursday as the company reports its first-quarter results. The animal health company reported adjusted earnings of $1.53 per share, missing the consensus of $1.61. Sales reached $2.26 billion, missing the consensus of...
by Avi Kapoor | May 7, 2026 | General
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. B of A Securities analyst Koji Ikeda downgraded Amplitude Inc...
Recent Comments